Peripheral oxytocin is associated with reduced symptom severity in schizophrenia.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Schizophrenia Research

• Publication date

  2010-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.schres.2010.09.014PMID 20947304PMCID PMC2981685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia.

  2011cited by this paper
• Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients.

  2010cited by this paper
• Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia.

  2010cited by this paper
• The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

  2010cited by this paper
• Preliminary evidence that plasma oxytocin levels are elevated in major depression.

  2010cited by this paper
• Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial.

  2010cited by this paper
• Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat.

  2010cited by this paper
• Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia.

  2009cited by this paper
• Sharing secrets: Oxytocin and trust in schizophrenia

  2009cited by this paper
• Oxytocin, vasopressin, and human social behavior.

  2009cited by this paper
• Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice

  2009cited by this paper
• Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness.

  2009cited by this paper
• Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia

  2009cited by this paper
• The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men.

  2009cited by this paper
• Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits.

  2008cited by this paper
• Estrogen in severe mental illness: a potential new treatment approach.

  2008cited by this paper
• Oxytocin, vasopressin and sociality.

  2008influential reference
• Short-Term Testosterone Augmentation in Male Schizophrenics: A Randomized, Double-Blind, Placebo-Controlled Trial

  2008cited by this paper
• Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects

  2008cited by this paper
• Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder.

  2007influential reference
• Plasma oxytocin levels and anxiety in patients with major depression.

  2007cited by this paper
• Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia

  2007influential reference
• Oxytocin: behavioral associations and potential as a salivary biomarker.

  2007influential reference
• Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia.

  2007cited by this paper
• Effect of hormone replacement therapy on cognitive function in women with chronic schizophrenia

  2006cited by this paper
• Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.

  2006cited by this paper
• Social Interaction Deficits Caused by Chronic Phencyclidine Administration are Reversed by Oxytocin

  2005cited by this paper
• Sex hormones in psychotic men.

  2005cited by this paper
• Oxytocin increases trust in humans

  2005cited by this paper
• Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study.

  2005influential reference
• Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women.

  2005cited by this paper
• Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics.

  2005influential reference
• Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats

  2005cited by this paper
• Oxytocin is associated with human trustworthiness.

  2005cited by this paper
• Cerebrospinal fluid neurophysins in affective illness and in schizophrenia

  2004cited by this paper
• Negative Correlation between Negative Symptoms of Schizophrenia and Testosterone Levels

  2004cited by this paper
• Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men.

  2004cited by this paper
• The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003.

  2004cited by this paper
• Improvement in Prosocial Functioning After a Switch to Ziprasidone Treatment

  2004cited by this paper
• Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication.

  2004cited by this paper
• Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis

  2004influential reference
• Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study.

  2004cited by this paper
• Oxytocin, But Not Oxytocin Receptor, is Regulated by Oestrogen Receptor β in the Female Mouse Hypothalamus

  2003cited by this paper
• Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia

  2003cited by this paper
• Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophrenia.

  2003cited by this paper
• Chlorpromazine equivalent doses for the newer atypical antipsychotics.

  2003cited by this paper
• Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.

  2003cited by this paper
• Hormonal aspects of schizophrenias: an overview.

  2003cited by this paper
• The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).

  2003cited by this paper
• A clinical trial of adjunctive oestrogen treatment in women with schizophrenia

  2002cited by this paper
• Changes in Premenstrual Symptoms in Women With Schizophrenia: A Prospective Study

  2001cited by this paper
• Estrogen affects cognition in women with psychosis.

  2000cited by this paper
• Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders.

  2000cited by this paper
• Gender aspects in schizophrenia: bridging the border between social and biological psychiatry

  2000cited by this paper
• Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women.

  2000cited by this paper
• Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating

  1999influential reference
• Estrogen receptor α is essential for induction of oxytocin receptor by estrogen

  1998cited by this paper
• Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults.

  1998influential reference
• Menstrually related symptom changes in women with schizophrenia.

  1997influential reference
• Structured Clinical Interview for DSM-IV Axis I Disorders

  1997cited by this paper
• Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet

  1997cited by this paper
• Role of oxytocin in the neuroadaptation to drugs of abuse.

  1994cited by this paper
• Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication.

  1994cited by this paper
• Can estradiol modulate schizophrenic symptomatology?

  1994cited by this paper
• Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia.

  1993cited by this paper
• Variation in symptom severity over the menstrual cycle of schizophrenics.

  1993cited by this paper
• Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics.

  1992cited by this paper
• Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity.

  1990cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987cited by this paper
• Vasopressin--oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls.

  1985influential reference
• Psychotropic properties of oxytocin

  1984influential reference
• Hormones in the treatment of psychoses.

  1972cited by this paper
• STEROID HORMONES AND SCHIZOPHRENIA

  year unknowncited by this paper

• Targeting the brain through the nose: Advances in polymeric nanoparticle delivery for schizophrenia.

  2026cites this paper
• A new two-hit animal model for schizophrenia research: Consequences on social behavior

  2025cites this paper
• Disruptions of the oxytocin system impair sociability and cognitive flexibility in a subchronic phencyclidine model of schizophrenia.

  2025cites this paper
• Oxytocin Deficiency in Childhood and Adolescence: Clinical Features, Diagnostic Challenges and Therapeutic Perspectives

  2025cites this paper
• The Etiological Role of Impaired Neurogenesis in Schizophrenia: Interactions with Inflammatory, Microbiome and Hormonal Signaling

  2025cites this paper
• The neurobiological impact of oxytocin in mental health disorders: a comprehensive review

  2025cites this paper
• Sex differences in plasma lipid profiles, but not in glucose metabolism in patients with first-episode antipsychotics-naïve schizophrenia.

  2024cites this paper
• Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia.

  2024cites this paper
• Interactions of Oxytocin and Dopamine—Effects on Behavior in Health and Disease

  2024cites this paper
• An exploration of blood-based biomarkers of negative symptoms of psychosis in men.

  2024cites this paper
• Understanding the Impact of Menopause on Women With Schizophrenia-Spectrum Disorders: A Comprehensive Review

  2023cites this paper
• Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up

  2023cites this paper
• The use of intranasal oxytocin in the treatment of eating disorders.

  2023cites this paper
• Sex Differences in Brain Disorders

  2023cites this paper
• Hippocampal subfield alterations in schizophrenia and major depressive disorder: a systematic review and network meta-analysis of anatomic MRI studies

  2023cites this paper
• Exploring a Possible Interplay between Schizophrenia, Oxytocin, and Estrogens: A Narrative Review

  2023influential citation
• The Interplay of Oxytocin and Attachment in Schizophrenic Patients: An fMRI Study

  2023cites this paper
• Update on Oxytocin, Phosphodiesterase, Neurokinin, Glycine as a Therapeutic Approach in the Treatment of Schizophrenia.

  2022cites this paper
• MDMA for the Treatment of Negative Symptoms in Schizophrenia

  2022cites this paper
• Oxytocin: An Old Hormone, A Novel Psychotropic Drug And Possible Use In Treating Psychiatric Disorders.

  2022cites this paper
• The Association Between Peripheral Oxytocin Levels and Depressive Symptoms in People With HIV

  2022cites this paper
• Two subtypes of schizophrenia identified by an individual-level atypical pattern of tensor-based morphometric measurement.

  2022cites this paper
• Premenstrual exacerbation of mental health disorders: a systematic review of prospective studies

  2022cites this paper
• Oxytocin and obsessive–compulsive disorder

  2022cites this paper
• The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance

  2022cites this paper
• Oxytocin receptor is not required for social attachment in prairie voles

  2022cites this paper
• Oxytocin: Narrative Expert Review of Current Perspectives on the Relationship with Other Neurotransmitters and the Impact on the Main Psychiatric Disorders

  2022cites this paper
• Early Life Trauma and Social Processing in HIV: The Role of Neuroendocrine Factors and Inflammation

  2022cites this paper
• Endogenous oxytocin levels are associated with facial emotion recognition accuracy but not gaze behavior in individuals with schizophrenia

  2022cites this paper
• Risk for midlife psychosis in women: critical gaps and opportunities in exploring perimenopause and ovarian hormones as mechanisms of risk

  2022cites this paper
• Peripheral oxytocin concentrations in psychiatric disorders - A systematic review and methanalysis: Further evidence.

  2022cites this paper
• Regulation of sex differences in risk-based decision making by gonadal hormones: insights from rodent models.

  2022cites this paper
• Rethinking the Architecture of Attachment: New Insights into the Role for Oxytocin Signaling

  2022cites this paper
• Plasma neuropeptide levels in patients with schizophrenia, bipolar disorder, or major depressive disorder and healthy controls: A multiplex immunoassay study

  2022cites this paper
• A computational lens on menopause-associated psychosis

  2022cites this paper
• Are serum oxytocin concentrations lower in patients with treatment-resistant schizophrenia?: A 5-year longitudinal study.

  2022cites this paper
• The effect of trehalose, antioxidants, and acetate buffer concentration on oxytocin stability

  2021cites this paper
• Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR.

  2021cites this paper
• Effect of 18-Crown-6 on Oxytocin Stability in Aqueous Buffer Solutions

  2021cites this paper
• Neural and Molecular Contributions to Pathological Jealousy and a Potential Therapeutic Role for Intranasal Oxytocin

  2021cites this paper
• Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment

  2021cites this paper
• Relationship Between Gonadal Hormone Levels and Symptom Severity in Female Patients With Schizophrenia

  2021cites this paper
• Oxytocin levels in individuals with schizophrenia are high in cerebrospinal uid but low in serum: A systematic review and meta-analysis

  2021cites this paper
• Measuring Affinity of Ligands to the Oxytocin Receptor Using Radioligand Binding.

  2021cites this paper
• Sex differences in P50 inhibition defects with psychopathology and cognition in patients with first-episode schizophrenia.

  2021cites this paper
• How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domain.

  2021cites this paper
• Oxytocin levels in individuals with schizophrenia are high in cerebrospinal fluid but low in serum: A systematic review and meta-analysis

  2021cites this paper
• Oxytocin-MCH circuit regulates monosynaptic inputs to MCH neurons and modulates social recognition memory.

  2020cites this paper
• Oxytocin and the Neurobiology of Prosocial Behavior

  2020cites this paper
• Schizophrenia and Sex Hormones: What Is the Link?

  2020cites this paper
• Oxytocin Signaling Pathway: From Cell Biology To Clinical Implications.

  2020cites this paper
• Low Serum Oxytocin Concentrations Are Associated with Painful Menstruation

  2020cites this paper
• Antipsychotic effects of sex hormones and atypical hemispheric asymmetries.

  2020cites this paper
• Distinct changes in chronic pain sensitivity and oxytocin receptor expression in a new rat model (Wisket) of schizophrenia.

  2020cites this paper
• Sex differences in association between clinical correlates and cognitive impairment in patients with chronic schizophrenia.

  2020cites this paper
• Neuroendocrine Networks and Functionality.

  2019cites this paper
• The Other Face of Oxytocin : Role of Oxytocin in Neuropsychiatric Disorders

  2019cites this paper
• Assessing the relationship between attachment, parental attitude and plasma oxytocin in schizophrenia patients and their unaffected siblings

  2019cites this paper
• [Oxytocin in schizophrenia : Evidence for an etiological and therapeutic relevance of the social neuromodulator].

  2019cites this paper
• Change of symptoms of schizophrenia across phases of menstrual cycle

  2019cites this paper
• Exacerbation of Psychosis During the Perimenstrual Phase of the Menstrual Cycle: Systematic Review and Meta-analysis

  2019cites this paper
• A biocultural approach to psychiatric illnesses

  2019cites this paper
• Hormonal Contraception and the Brain: Examining Cognition and Psychiatric Disorders

  2019cites this paper
• Hypothalamic-pituitary-gonadal axis dysfunction: An innate pathophysiology of schizophrenia?

  2019cites this paper
• Reduced DNA Methylation of the Oxytocin Receptor Gene Is Associated With Anhedonia-Asociality in Women With Recent-Onset Schizophrenia and Ultra-high Risk for Psychosis.

  2019cites this paper
• Menstrual cycle-related fluctuations in oxytocin concentrations: A systematic review and meta-analysis.

  2019cites this paper
• Évolution de la symptomatologie négative chez les patients schizophrènes hospitalisés

  2019cites this paper
• Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia.

  2019cites this paper
• Yoga: Balancing the excitation-inhibition equilibrium in psychiatric disorders.

  2019cites this paper
• The Effect of Intranasal Oxytocin on Measures of Social Cognition in Schizophrenia: A Negative Report

  2019cites this paper
• NONHUMAN ANIMALS ARE MORALLY RESPONSIBLE

  2019cites this paper
• Sex and gender differences in schizophrenic psychoses—a critical review

  2018cites this paper
• Saliva oxytocin measures do not reflect peripheral plasma concentrations after intranasal oxytocin administration in men

  2018cites this paper
• Sex difference in association of symptoms and white matter deficits in first-episode and drug-naive schizophrenia

  2018cites this paper
• Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia.

  2018cites this paper
• Testosterone, DHEA and DHEA-S in patients with schizophrenia: A systematic review and meta-analysis.

  2018cites this paper
• Peripheral Oxytocin Predicts Higher-Level Social Cognition in Men Regardless of Empathy Quotient

  2018cites this paper
• Oxytocin bei Schizophrenie

  2018cites this paper
• Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment – need for more short- and long-term studies

  2018cites this paper
• Atrial natriuretic peptide and posterior pituitary neurohormone changes in patients with acute schizophrenia

  2018cites this paper
• The effects of combined oxytocin and cognitive behavioral social skills training on social cognition in schizophrenia

  2018cites this paper
• Oxytocin and Schizophrenia Spectrum Disorders.

  2018cites this paper
• Sex hormones and schizophrenia: from animal behavioural models to gene targets

  2018influential citation
• The effects of adjunctive intranasal oxytocin in patients with schizophrenia

  2018cites this paper
• Rare missense coding variants in oxytocin receptor (OXTR) in schizophrenia cases are associated with early trauma exposure, cognition and emotional processing.

  2018cites this paper
• Endogenous oxytocin response to film scenes of attachment and loss is pronounced in schizophrenia

  2018cites this paper
• Influence of Hormonal Status and Menstrual Cycle Phase on Psychopatology in Acute Admitted Patients with Schizophrenia.

  2018cites this paper
• The relationship between oxytocin pathway genes and personality traits and psychosis characteristics

  2017cites this paper
• Oxytocin and social cognition in patients with schizophrenia: comparison with healthy siblings and healthy controls

  2017cites this paper
• The current conceptualization of negative symptoms in schizophrenia

  2017cites this paper
• Peripheral oxytocin and vasopressin are associated with clinical symptom severity and cognitive functioning in midlife women with chronic schizophrenia.

  2017cites this paper
• Effects of intranasal oxytocin on symptoms of schizophrenia: A multivariate Bayesian meta-analysis.

  2017cites this paper
• Oxytocin and Brain Plasticity

  2017cites this paper
• Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders

  2017cites this paper
• The role of oxytocin in the pathogenesis and treatment of schizophrenia

  2017influential citation
• Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders.

  2017cites this paper
• Oxytocin trajectories and social engagement in extremely premature infants during NICU hospitalization.

  2017cites this paper
• Neuroendocrine Networks and Functionality.

  2017cites this paper
• Do blood plasma levels of oxytocin moderate the effect of nasally administered oxytocin on social orienting in high-functioning male adults with autism spectrum disorder?

  2016cites this paper
• Interaction of oxytocin level and past depression may predict postpartum depressive symptom severity

  2016cites this paper